| Second malignancies from adjuvant chemotherapy? Too soon to tell |
| IC Henderson and R Gelman |
|
JCO Aug 1 1987: 1135–1137.
[PDF]
|
 |
|
Second malignancies after CMF for resectable breast cancer |
| |
P Valagussa, G Tancini, and G Bonadonna |
| |
JCO Aug 1 1987: 1138–1142.
[Abstract]
[PDF]
|
|
|
Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus |
| |
AA Forastiere, M Gennis, MB Orringer, and FP Agha |
| |
JCO Aug 1 1987: 1143–1149.
[Abstract]
[PDF]
|
|
|
A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma |
| |
SG Arbuck, HO Douglass, Jr, F Trave, S Milliron, M Baroni, H Nava, LJ Emrich, and YM Rustum |
| |
JCO Aug 1 1987: 1150–1156.
[Abstract]
[PDF]
|
|
|
Randomized trial comparing two combination chemotherapy regimens (CHAP- 5 v CP) in advanced ovarian carcinoma |
| |
JP Neijt, WW ten Bokkel Huinink, ME van der Burg, AT van Oosterom, PH Willemse, AP Heintz, M van Lent, JB Trimbos, J Bouma, and JB Vermorken |
| |
JCO Aug 1 1987: 1157–1168.
[Abstract]
[PDF]
|
|
|
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs |
| |
JB Sorensen, HH Hansen, P Dombernowsky, E Bork, R Malmberg, K Aabo, B Bodker, and M Hansen |
| |
JCO Aug 1 1987: 1169–1177.
[Abstract]
[PDF]
|
|
|
Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III |
| |
AM Goorin, A Perez-Atayde, M Gebhardt, JW Andersen, RH Wilkinson, MJ Delorey, H Watts, M Link, N Jaffe, and E Frei, 3d |
| |
JCO Aug 1 1987: 1178–1184.
[Abstract]
[PDF]
|
|
|
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy |
| |
J Nachman, MA Simon, L Dean, D Shermeta, P Dawson, and NJ Vogelzang |
| |
JCO Aug 1 1987: 1185–1190.
[Abstract]
[PDF]
|
|
|
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults |
| |
JS Miser, TJ Kinsella, TJ Triche, M Tsokos, P Jarosinski, R Forquer, R Wesley, and I Magrath |
| |
JCO Aug 1 1987: 1191–1198.
[Abstract]
[PDF]
|
|
|
Metastatic Ewing's sarcoma: remission induction and survival |
| |
FA Hayes, EI Thompson, L Parvey, B Rao, L Kun, D Parham, and HO Hustu |
| |
JCO Aug 1 1987: 1199–1204.
[Abstract]
[PDF]
|
|
|
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma |
| |
O Hartmann, E Benhamou, F Beaujean, C Kalifa, O Lejars, C Patte, C Behard, F Flamant, A Thyss, and A Deville |
| |
JCO Aug 1 1987: 1205–1211.
[Abstract]
[PDF]
|
|
|
Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience |
| |
Sr Loehrer PJ, R Birch, SD Williams, FA Greco, and LH Einhorn |
| |
JCO Aug 1 1987: 1212–1220.
[Abstract]
[PDF]
|
|
|
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy |
| |
TW Pendergrass, JM Milstein, JR Geyer, AF Mulne, EJ Kosnik, JD Morris, RL Heideman, FB Ruymann, JT Stuntz, and WA Bleyer |
| |
JCO Aug 1 1987: 1221–1231.
[Abstract]
[PDF]
|
|
|
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma |
| |
PH Wiernik, EL Schwartz, A Einzig, JJ Strauman, RB Lipton, and JP Dutcher |
| |
JCO Aug 1 1987: 1232–1239.
[Abstract]
[PDF]
|
|
|
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules [published erratum appears in J Clin Oncol 1987 Nov;5(11):1858] |
| |
SS Legha, NE Papadopoulos, C Plager, S Ring, SP Chawla, LM Evans, and RS Benjamin |
| |
JCO Aug 1 1987: 1240–1246.
[Abstract]
[PDF]
|
|
|
Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018) |
| |
JM Kirkwood, RD Neumann, SS Zoghbi, MS Ernstoff, EA Cornelius, C Shaw, T Ziyadeh, JA Fine, and MW Unger |
| |
JCO Aug 1 1987: 1247–1255.
[Abstract]
[PDF]
|
|
|
Estrogen receptor in malignant melanoma |
| |
MJ Walker, CW Beattie, MK Patel, SM Ronan, and TK Das Gupta |
| |
JCO Aug 1 1987: 1256–1261.
[Abstract]
[PDF]
|
|
|
Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival |
| |
DK Wagner, J Kiwanuka, BK Edwards, LA Rubin, DL Nelson, and IT Magrath |
| |
JCO Aug 1 1987: 1262–1274.
[Abstract]
[PDF]
|
|
|
Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy |
| |
JD Hainsworth, EP Wright, GF Gray, Jr, and FA Greco |
| |
JCO Aug 1 1987: 1275–1280.
[Abstract]
[PDF]
|
|
|
Platinum analogue combination chemotherapy: cisplatin and carboplatin-- a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion |
| |
DL Trump, JL Grem, KD Tutsch, JK Willson, KJ Simon, D Alberti, B Storer, and DC Tormey |
| |
JCO Aug 1 1987: 1281–1289.
[Abstract]
[PDF]
|
|
|
Klinefelter's syndrome associated with mediastinal germ cell neoplasms |
| |
CR Nichols, NA Heerema, C Palmer, Sr Loehrer PJ, SD Williams, and LH Einhorn |
| |
JCO Aug 1 1987: 1290–1294.
[Abstract]
[PDF]
|
|
|
Spontaneous fracture of the catheter of a totally implantable venous access port: case report of a rare complication |
| |
J Noyen, J Hoorntje, Z de Langen, JW Leemslag, and D Sleijfer |
| |
JCO Aug 1 1987: 1295–1299.
[Abstract]
[PDF]
|
|
| Effects of patient management guidelines on physician practice patterns: the Community Hospital Oncology Program experience |
| MI Feldman |
|
JCO Aug 1 1987: 1300a.
[PDF]
|
|
| Authors should not compare survival of responders and nonresponders without discussing the limitations of such a comparison |
| MS Piver |
|
JCO Aug 1 1987: 1300b–1302.
[PDF]
|
|
| Minimizing toxicity of MACOP-B |
| JM Connors and P Klimo |
|
JCO Aug 1 1987: 1302–1303.
[PDF]
|
|
| Irreversible encephalopathy with ifosfamide/mesna |
| E Salloum, F Flamant, M Ghosn, N Taleb, and C Akatchereian |
|
JCO Aug 1 1987: 1303–1304.
[PDF]
|
|
| Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs |
| P Fenaux, JP Jouet, F Bauters, JL Lai, and P Lepelley |
|
JCO Aug 1 1987: 1304–1305.
[PDF]
|
|
